Ardelyx, Inc.

NasdaqGM:ARDX Lagerbericht

Marktkapitalisierung: US$1.1b

Ardelyx Management

Management Kriterienprüfungen 3/4

Ardelyx CEO ist Mike Raab , ernannt in Mar 2009, hat eine Amtszeit von 15.67 Jahren. Die jährliche Gesamtvergütung beträgt $4.12M , bestehend aus 17% Gehalt und 83% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.52% der Aktien des Unternehmens, im Wert von $5.56M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 4.2 Jahre bzw. 9.1 Jahre.

Wichtige Informationen

Mike Raab

Geschäftsführender

US$4.1m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts17.0%
Amtszeit als Geschäftsführer15.7yrs
Eigentum des Geschäftsführers0.5%
Durchschnittliche Amtszeit des Managements4.2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder9.1yrs

Jüngste Management Updates

Recent updates

Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability

Nov 14

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Nov 03
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business

Oct 24
Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business

Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?

Aug 25
Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?

Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Aug 07
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Ardelyx Faces Rising Challenges Despite Revenue Growth

Aug 05

Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 04
Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook

Jul 13

Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge

Jul 05
Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge

Ardelyx: Strong Execution, Fairly Valued

May 10

Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

May 04
Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)

May 03

Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing

Apr 17
Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing

Ardelyx Shrugs Off 'Mixed' Q4 Earnings

Mar 13

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Feb 24
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance

Feb 20

Ardelyx's XPHOZAH Still An Afterthought To The Pros

Jan 31

Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement

Jan 10

Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price

Jan 04
Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price

Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt

Dec 14
Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt

Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Aug 03
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts

Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt

Jul 31
Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt

Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now

Apr 17
Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now

Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Mar 30
Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

Dec 14
Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?

What To Expect For Ardelyx In The Coming Month

Oct 18

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Mike Raab im Vergleich zu den Einnahmen von Ardelyx verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

-US$73m

Jun 30 2024n/an/a

-US$65m

Mar 31 2024n/an/a

-US$66m

Dec 31 2023US$4mUS$700k

-US$66m

Sep 30 2023n/an/a

-US$27m

Jun 30 2023n/an/a

-US$56m

Mar 31 2023n/an/a

-US$66m

Dec 31 2022US$2mUS$650k

-US$67m

Sep 30 2022n/an/a

-US$114m

Jun 30 2022n/an/a

-US$135m

Mar 31 2022n/an/a

-US$153m

Dec 31 2021US$4mUS$650k

-US$158m

Sep 30 2021n/an/a

-US$151m

Jun 30 2021n/an/a

-US$125m

Mar 31 2021n/an/a

-US$105m

Dec 31 2020US$4mUS$633k

-US$94m

Sep 30 2020n/an/a

-US$85m

Jun 30 2020n/an/a

-US$91m

Mar 31 2020n/an/a

-US$91m

Dec 31 2019US$2mUS$595k

-US$95m

Sep 30 2019n/an/a

-US$103m

Jun 30 2019n/an/a

-US$104m

Mar 31 2019n/an/a

-US$100m

Dec 31 2018US$4mUS$575k

-US$91m

Sep 30 2018n/an/a

-US$53m

Jun 30 2018n/an/a

-US$50m

Mar 31 2018n/an/a

-US$53m

Dec 31 2017US$5mUS$555k

-US$64m

Vergütung im Vergleich zum Markt: MikeDie Gesamtvergütung ($USD4.12M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD3.18M).

Entschädigung vs. Einkommen: MikeDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

Mike Raab (59 yo)

15.7yrs

Amtszeit

US$4,118,144

Vergütung

Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Michael Raab
President15.7yrsUS$4.12m0.52%
$ 5.6m
Elizabeth Grammer
Chief Legal & Administrative Officer and Secretary10.5yrsUS$1.63m0.081%
$ 865.7k
Laura Williams
Chief Medical Officer4yrsUS$1.63m0.13%
$ 1.4m
Justin Renz
Chief Financial & Operations Officer4.4yrsUS$1.73m0.12%
$ 1.3m
Robert Felsch
Senior VP of Finance & Chief Accounting Officer2.7yrskeine Daten0.039%
$ 412.1k
Caitlin Lowie
Vice President of Corporate Communications & Investor Relationsno datakeine Datenkeine Daten
Mike Kelliher
Executive Vice President of Corporate Development & Strategyless than a yearkeine Datenkeine Daten
Charon Spencer
Chief Human Resources Officer1.8yrskeine Datenkeine Daten
David Rosenbaum
Chief Development Officer9.8yrsUS$1.63m0.23%
$ 2.4m
Robert Blanks
Chief Regulatory Affairs & Quality Assurance Officerno dataUS$1.70m0.13%
$ 1.4m
Susan Rodriguez
Advisor4.5yrsUS$1.04m0.19%
$ 2.0m
Eric Foster
Chief Commercial Officerless than a yearkeine Datenkeine Daten

4.2yrs

Durchschnittliche Betriebszugehörigkeit

60yo

Durchschnittliches Alter

Erfahrenes Management: ARDXDas Führungsteam des Unternehmens gilt als erfahren (4.2 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Michael Raab
President15.7yrsUS$4.12m0.52%
$ 5.6m
David Mott
Independent Chairman of the Board15.7yrsUS$249.90k0.51%
$ 5.4m
William C. Bertrand
Independent Director9.1yrsUS$214.90k0.097%
$ 1.0m
Richard Rodgers
Independent Director10.7yrsUS$222.40k0.11%
$ 1.1m
Robert Bazemore
Independent Director8.4yrsUS$202.40kkeine Daten
Onaiza Cadoret-Manier
Independent Director4.7yrsUS$199.90k0.047%
$ 495.7k
Muna Bhanji
Independent Director3.7yrsUS$202.40k0.040%
$ 431.1k

9.1yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: ARDXDie Vorstandsmitglieder gelten als erfahren (9.1 Jahre durchschnittliche Amtszeit).